CRISPR gene editing shows promise for treating individuals w

Results from a groundbreaking clinical trial of CRISPR gene editing in 14 individuals with a form of inherited blindness show that the treatment is safe and led to measurable improvements in 11 of the participants treated.

Related Keywords

University Of Pennsylvania , Pennsylvania , United States , Philadelphia , Mark Pennesi , Irene Heinz , Tomass Aleman , Baisong Mei , Harvard Medical School , Hospital Of The University Pennsylvania , Cell Therapy Institute , Editas Medicine Inc , Wk Kellogg Eye Center , Scheie Eye Institute , Bascom Palmer Eye Institute , Ocular Genomics Institute , Eric Pierce , Mass Eye , Mass General Brigham , Editas Medicine , New England Journal , Berman Gund Laboratory , Retinal Degenerations , Harvard Medical , Leber Congenital Amaurosis , Chief Medical Officer , General Brigham , Casey Eye Institute , Oregon Health , Science University , Eye Center , Irene Heinz Given , John Laporte Research Professor , Penn Medicine , Blindness , Clinical Trial , Gene , Cas9 , Children , Rispr , Ear , Efficacy , Eye , Wood , Gene Therapy , Gene Editing , Enetic , Enome , Genome Editing , Genomics , Healthcare , Hearing , Hospital , Laboratory , Medical School , Medicine , Neck , Ophthalmology , Protein , Research , Retinal Degeneration , Throat , Vision Loss ,